Aslan on SPi NewsFollow our SPi News RSS Feed for aslan

Featured aslan News

[27 Nov 2018] ASLAN Pharmaceuticals Announces Acceptance of Abstracts on New Varlitinib Data in BTC at ASCO Gastrointestinal Cancers Symposium

[20 Nov 2018] Aslan Pharmaceuticals to Participate in 30th Annual Piper Jaffray Healthcare Conference

[08 Nov 2018] ASLAN Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update

[01 Nov 2018] ASLAN Pharmaceuticals to Present New Data on ASLAN003 at American Society of Hematology Annual Meeting

[30 Oct 2018] ASLAN Pharmaceuticals Appoints Robert E. Hoffman as Independent Director

[22 Oct 2018] New Data Presented on ASLAN’s varlitinib at ESMO Show Promising Results in Heavily Pre-Treated BTC and CRC Patients

[17 Oct 2018] ASLAN Pharmaceuticals Enrolls First Subject in Phase 1 Study for ASLAN004 in Atopic Dermatitis

[09 Oct 2018] ASLAN Pharmaceuticals to Present Posters on Varlitinib and ASLAN003 at European Society for Medical Oncology Congress

[21 Sep 2018] ASLAN Pharmaceuticals Presents Two Posters on Varlitinib at Chinese Society of Clinical Oncology Annual Meeting

[19 Sep 2018] Edison issues update on ASLAN Pharmaceuticals (ASLN)

[17 Sep 2018] ASLAN Pharmaceuticals Provides Update on Timelines for Clinical Trial of Varlitinib in Biliary Tract Cancer in China

[04 Sep 2018] ASLAN Pharmaceuticals to Present at HC Wainwright 20th Annual Global Investment Conference

[20 Aug 2018] ASLAN Pharmaceuticals Granted Orphan Drug Designation by the FDA for ASLAN003 for the Treatment of Acute Myeloid Leukaemia

[10 Aug 2018] ASLAN Pharmaceuticals Completes Recruitment for Global Phase 2 Study for Varlitinib in First Line Gastric Cancer

[06 Aug 2018] ASLAN Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update

[09 Jul 2018] Edison issues update on ASLAN Pharmaceuticals (ASLN)

[03 Jul 2018] ASLAN Pharmaceuticals Submits Clinical Trial Authorisation Application for First in Man Studies for ASLAN004

[08 Jun 2018] Edison issues update on ASLAN Pharmaceuticals (ASLN)

[17 May 2018] ASLAN Pharmaceuticals to Present Two Posters on Varlitinib at ASCO

[04 May 2018] ASLAN Pharmaceuticals Prices Initial Public Offering of Its American Depositary Shares

[17 Apr 2018] ASLAN Pharmaceuticals Announces Presentation of New Pre-Clinical Data on Varlitinib in Hepatocellular Carcinoma at AACR

[27 Mar 2018] Aslan Pharmaceuticals Files for Proposed Initial Public Offering in the U.S.

[27 Mar 2018] Aslan Pharmaceuticals Files for Proposed Initial Public Offering in the U.S.

[27 Mar 2018] Aslan Pharmaceuticals Files for Proposed Initial Public Offering in the U.S.

[27 Mar 2018] Aslan Pharmaceuticals Files for Proposed Initial Public Offering in the U.S.

[27 Mar 2018] Aslan Pharmaceuticals Files for Proposed Initial Public Offering in the U.S.

[27 Mar 2018] Aslan Pharmaceuticals Files for Proposed Initial Public Offering in the U.S.

[27 Mar 2018] Aslan Pharmaceuticals Files for Proposed Initial Public Offering in the U.S.

[27 Mar 2018] Aslan Pharmaceuticals Files for Proposed Initial Public Offering in the U.S.

[27 Mar 2018] Aslan Pharmaceuticals Files for Proposed Initial Public Offering in the U.S.

[27 Mar 2018] Aslan Pharmaceuticals Files for Proposed Initial Public Offering in the U.S.

[31 Jan 2018] ASLAN Pharmaceuticals Sponsors Cholangiocarcinoma Foundation Annual Conference 2018

[18 Jan 2018] ASLAN Pharmaceuticals Appoints Stephen Doyle as Head of China

[08 Jan 2018] ASLAN Pharmaceuticals Announces Shortened Timeline to Commercialisation for Varlitinib in China

[04 Jan 2018] ASLAN Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

[03 Jan 2018] ASLAN Pharmaceuticals Acquires Full Global Commercial Rights for Varlitinib From Array BioPharma

[23 Mar 2016] Femasys Appoints Fred Aslan and Charles Larsen to its Board of Directors


Still looking?

Type in your search term below and click Enter

World News from SPi

Sector Publishing Intelligence [SPi'] publishes financial news from around the world FAST. For breaking news announcements from companies, blogs and commentators, SPi provides up to the minute, integrated news on all aspects of financial markets and financial services.

The SPi Financial News Search gets results from our extensive news archives containing 10’s of thousands of news reports. Intelligent cross referencing of stories and background gives readers and researchers highly relevant related information about topics and businesses in the finance sector.

Trending financial topics highlight the most recent themes in the news. Thousands of financial topics can be followed using RSS, or join hundreds of SPis Financial News followers on Twitter for instant news as soon as it’s published on SPi. @SPiFinancialSvc

SPi's extensive database of corporate information shows company details alongside breaking corporate news from the world’s largest news providers.

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us